Concentric Analgesics, Inc. — Form D/A
Concentric Analgesics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2016-09-26. The offering totals $9.6M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-09-26
- Form: D/A
- Accession: 0001682398-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.6M
- Amount sold: $6.0M
- Remaining: $3.6M
- Investors: 63
- Date of first sale: 2016-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-269098
Issuer
- Name: Concentric Analgesics, Inc.
- CIK: 0001682398
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 101 California Street, SAN FRANCISCO, CA, 94111
- Phone: 415-484-7921
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Thomas King | Director | Brooklyn, NY |
| Thomas King | Executive Officer | Brooklyn, NY |
| John Donovan | Director | Houston, TX |
| John Donovan | Executive Officer | Houston, TX |
| John F Donovan | Director | San Francisco, CA |
| John F Donovan | Executive Officer | San Francisco, CA |
| Frank J Bellizzi | Director | San Francisco, CA |
| Frank J Bellizzi | Executive Officer | San Francisco, CA |
| Thomas F King | Director | San Francisco, CA |
| Thomas F King | Executive Officer | San Francisco, CA |
| Larry F Feinberg | Director | San Francisco, CA |
| Frank Bellizzi | Director | San Francisco, CA |
| Frank Bellizzi | Executive Officer | San Francisco, CA |
| Craig Husfeld | Director | San Francisco, CA |
| Craig Husfeld | Executive Officer | San Francisco, CA |
| Craig F Husfeld | Director | Los Altos, CA |
Other filings by this issuer (8)
More